United Therapeutics (UTHR) Q3 2026 Earnings Report

MX:UTHR Q3 2026 EPS Results

Actual EPS: ―
Consensus EPS: MXN 111.61
Beat/Miss: ―
One Year Ago EPS: MXN 133.04

MX:UTHR Q3 2026 Revenue Results

Actual Revenue: ―
Expected Revenue: MXN 14.51B
Beat/Miss: ―
YoY Revenue Growth: ―

Earnings Announcement Details

Quarter: Q3 2026
Date: 11/04/2026
Time: Before Open
Conference Call: Wednesday, November 4, 2026

Q3 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

MX:UTHR Earnings History

MX:UTHR earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 04, 2026	2026 (Q3)	111.61-	133.04	―
Aug 05, 2026	2026 (Q2)	127.50135.08	119.1	13.42% (+15.98)
May 06, 2026	2026 (Q1)	130.03108.14	123.19	-12.22% (-15.05)
Feb 25, 2026	2025 (Q4)	132.48143.07	115.02	24.39% (+28.06)
Oct 29, 2025	2025 (Q3)	135.96133.04	118.73	12.05% (+14.31)
Jul 30, 2025	2025 (Q2)	135.55119.10	108.7	9.57% (+10.41)
Apr 30, 2025	2025 (Q1)	124.42123.19	114.64	7.46% (+8.55)
Feb 26, 2025	2024 (Q4)	118.92115.02	81.01	41.97% (+34.00)
Oct 30, 2024	2024 (Q3)	121.20118.73	99.96	18.77% (+18.77)
Jul 31, 2024	2024 (Q2)	120.87108.70	97.36	11.64% (+11.33)
May 01, 2024	2024 (Q1)	106.69114.64	90.3	26.95% (+24.34)
Feb 21, 2024	2023 (Q4)	77.8081.01	49.61	63.30% (+31.40)
Nov 01, 2023	2023 (Q3)	94.8099.96	91.23	9.57% (+8.73)
Aug 02, 2023	2023 (Q2)	84.9097.36	44.78	117.43% (+52.58)
May 03, 2023	2023 (Q1)	85.2590.30	93.46	-3.38% (-3.16)
Feb 22, 2023	2022 (Q4)	87.7449.61	65.22	-23.93% (-15.61)
Nov 02, 2022	2022 (Q3)	72.6591.23	63.55	43.57% (+27.69)
Aug 03, 2022	2022 (Q2)	81.5544.78	67.82	-33.97% (-23.04)
May 04, 2022	2022 (Q1)	67.7593.46	11.33	724.59% (+82.13)
Feb 24, 2022	2021 (Q4)	66.5265.22	40.69	60.27% (+24.53)
Nov 03, 2021	2021 (Q3)	66.7463.55	71.35	-10.94% (-7.80)
Aug 04, 2021	2021 (Q2)	56.1167.82	44.78	51.45% (+23.04)
May 05, 2021	2021 (Q1)	―11.33	57.97	-80.45% (-46.64)
Feb 24, 2021	2020 (Q4)	―40.69	22.3	82.50% (+18.39)
Oct 28, 2020	2020 (Q3)	―71.35	55.93	27.57% (+15.42)
Jul 29, 2020	2020 (Q2)	―44.78	86.59	-48.28% (-41.81)
Apr 29, 2020	2020 (Q1)	―57.97	-210.33	127.56% (+268.31)
Feb 26, 2020	2019 (Q4)	―22.30	27.5	-18.92% (-5.20)
Oct 30, 2019	2019 (Q3)	―55.93	44.97	24.38% (+10.96)
Jul 31, 2019	2019 (Q2)	―86.59	73.95	17.09% (+12.63)
May 01, 2019	2019 (Q1)	―-210.33	103.5	-303.23% (-313.83)
Feb 27, 2019	2018 (Q4)	―27.50	7.99	244.19% (+19.51)
Oct 31, 2018	2018 (Q3)	―44.97	116.5	-61.40% (-71.54)
Aug 01, 2018	2018 (Q2)	―73.95	-23.23	418.40% (+97.18)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

United Therapeutics earnings date